Article
Can circulating cell free DNA be a promising marker in ovarian cancer? – a genome-scale profiling study in a single institution
14 Jan 2023
Abstract excerpt
BACKGROUND: Cell-free DNA (cfDNA) is emerging as a potential biomarker for the detection of ovarian cancer (OC). Recently, we reported a method based upon cfDNA whole-genome sequencing data including the nucleosome distribution (nucleosome footprinting NF), terminal signature sequence (motif), DNA fragmentation (fragment), and copy number variation (CNV).In the present study, we explored whether multiomics early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
